Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASGI
4576
abrdn Global Infrastructure Income Fund
ASGI
$757M
| $1.75M | ﹤0.01% |
87,904
+3,901
| +5% | +$81.5K |
|
|
BLCT
4577
DELISTED
BlueCity Holdings Limited American Depositary Shares
BLCT
| $1.75M | ﹤0.01% |
584,005
-142,679
| -20% | -$702K |
|
4578
Northeast Bank
NBN
$1.12B
| $1.74M | ﹤0.01% |
51,652
-15,330
| -23% | -$491K |
|
4579
Krystal Biotech
KRYS
$9.58B
| $1.74M | ﹤0.01% |
33,234
-10,217
| -24% | -$605K |
|
|
ADAP
4580
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.73M | ﹤0.01% |
334,971
-1,953,560
| -85% | -$8.76M |
|
|
AUD
4581
DELISTED
Audacy, Inc.
AUD
| $1.73M | ﹤0.01% |
470,651
-230,808
| -33% | -$808K |
|
|
JSD
4582
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $1.72M | ﹤0.01% |
114,117
+72,400
| +174% | +$1.07M |
|
4583
iShares Interest Rate Hedged Long-Term Corporate Bond ETF
IGBH
$221M
| $1.72M | ﹤0.01% |
68,437
-467
| -0.7% | -$11.8K |
|
|
LX
4584
LexinFintech Holdings
LX
$236M
| $1.72M | ﹤0.01% |
292,129
-21,187
| -7% | -$163K |
|
4585
Alaunos Therapeutics
TCRT
$4.88M
| $1.72M | ﹤0.01% |
6,303
-673
| -10% | -$206K |
|
4586
Tilly's
TLYS
$127M
| $1.72M | ﹤0.01% |
122,805
+74,106
| +152% | +$1.13M |
|
|
AKYA
4587
DELISTED
Akoya BioSciences
AKYA
| $1.72M | ﹤0.01% |
123,151
+12,649
| +11% | +$211K |
|
4588
WisdomTree Enhanced Commodity Strategy Fund
GCC
$275M
| $1.72M | ﹤0.01% |
76,896
+31,817
| +71% | +$700K |
|
|
MGI
4589
DELISTED
MoneyGram International, Inc. New
MGI
| $1.71M | ﹤0.01% |
213,384
-161,313
| -43% | -$1.54M |
|
4590
Banco Macro
BMA
$5.45B
| $1.71M | ﹤0.01% |
100,665
-2,808
| -3% | -$44.4K |
|
4591
CorMedix
CRMD
$588M
| $1.71M | ﹤0.01% |
367,688
+64,063
| +21% | +$373K |
|
4592
Seneca Foods Class A
SENEA
$1.14B
| $1.71M | ﹤0.01% |
35,438
-2,371
| -6% | -$120K |
|
4593
Kimbell Royalty Partners
KRP
$1.51B
| $1.71M | ﹤0.01% |
120,842
-232,999
| -66% | -$2.78M |
|
4594
Harmony Biosciences
HRMY
$2.27B
| $1.71M | ﹤0.01% |
44,484
-84,272
| -65% | -$2.71M |
|
|
IBA
4595
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $1.7M | ﹤0.01% |
38,526
+9,525
| +33% | +$426K |
|
4596
GT Biopharma
GTBP
$11.8M
| $1.7M | ﹤0.01% |
8,410
+7,249
| +624% | +$2.18M |
|
4597
MediaAlpha
MAX
$820M
| $1.7M | ﹤0.01% |
90,868
+29,046
| +47% | +$786K |
|
|
BCIC
4598
BCP Investment Corp
BCIC
$91.8M
| $1.7M | ﹤0.01% |
69,686
+41,242
| +145% | +$991K |
|
|
BTA
4599
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
| $1.69M | ﹤0.01% |
125,301
+173
| +0.1% | +$2.42K |
|
4600
SELLAS Life Sciences
SLS
$2.34B
| $1.69M | ﹤0.01% |
184,868
+169,369
| +1,093% | +$1.57M |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,331 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.